Global Peripheral Neuropathy Treatment Market Research Report 2023

Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is not a single, homogenous disease, but it is a mix of different clinical presentations, natural histories, and pathology.

The global Peripheral Neuropathy Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Peripheral Neuropathy Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Peripheral Neuropathy Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Peripheral Neuropathy Treatment in Platinum Agents is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Peripheral Neuropathy Treatment include Eli Lilly, Johnson & Johnson, Novartis, Pfizer, Aptinyx, Regenacy Pharmaceuticals, TEVA Pharmaceutical Industries and Immune Pharmaceuticals, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Peripheral Neuropathy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Neuropathy Treatment.

The Peripheral Neuropathy Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Peripheral Neuropathy Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peripheral Neuropathy Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peripheral Neuropathy Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Calcium Channel α2-delta Ligands

1.2.3 Antidepressants

1.2.4 Opioids

1.2.5 Others

1.3 Market by Application

1.3.1 Global Peripheral Neuropathy Treatment Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Platinum Agents

1.3.3 Taxanes

1.3.4 Vinca Alkaloids

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Peripheral Neuropathy Treatment Market Perspective (2018-2029)

2.2 Peripheral Neuropathy Treatment Growth Trends by Region

2.2.1 Global Peripheral Neuropathy Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Peripheral Neuropathy Treatment Historic Market Size by Region (2018-2023)

2.2.3 Peripheral Neuropathy Treatment Forecasted Market Size by Region (2024-2029)

2.3 Peripheral Neuropathy Treatment Market Dynamics

2.3.1 Peripheral Neuropathy Treatment Industry Trends

2.3.2 Peripheral Neuropathy Treatment Market Drivers

2.3.3 Peripheral Neuropathy Treatment Market Challenges

2.3.4 Peripheral Neuropathy Treatment Market Restraints

3.1 Global Top Peripheral Neuropathy Treatment Players by Revenue

3.1.1 Global Top Peripheral Neuropathy Treatment Players by Revenue (2018-2023)

3.1.2 Global Peripheral Neuropathy Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Peripheral Neuropathy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Peripheral Neuropathy Treatment Revenue

3.4 Global Peripheral Neuropathy Treatment Market Concentration Ratio

3.4.1 Global Peripheral Neuropathy Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peripheral Neuropathy Treatment Revenue in 2022

3.5 Peripheral Neuropathy Treatment Key Players Head office and Area Served

3.6 Key Players Peripheral Neuropathy Treatment Product Solution and Service

3.7 Date of Enter into Peripheral Neuropathy Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Peripheral Neuropathy Treatment Historic Market Size by Type (2018-2023)

4.2 Global Peripheral Neuropathy Treatment Forecasted Market Size by Type (2024-2029)

5.1 Global Peripheral Neuropathy Treatment Historic Market Size by Application (2018-2023)

5.2 Global Peripheral Neuropathy Treatment Forecasted Market Size by Application (2024-2029)

6.1 North America Peripheral Neuropathy Treatment Market Size (2018-2029)

6.2 North America Peripheral Neuropathy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Peripheral Neuropathy Treatment Market Size by Country (2018-2023)

6.4 North America Peripheral Neuropathy Treatment Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Peripheral Neuropathy Treatment Market Size (2018-2029)

7.2 Europe Peripheral Neuropathy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Peripheral Neuropathy Treatment Market Size by Country (2018-2023)

7.4 Europe Peripheral Neuropathy Treatment Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Peripheral Neuropathy Treatment Market Size (2018-2029)

8.2 Asia-Pacific Peripheral Neuropathy Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Region (2018-2023)

8.4 Asia-Pacific Peripheral Neuropathy Treatment Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Peripheral Neuropathy Treatment Market Size (2018-2029)

9.2 Latin America Peripheral Neuropathy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Peripheral Neuropathy Treatment Market Size by Country (2018-2023)

9.4 Latin America Peripheral Neuropathy Treatment Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Peripheral Neuropathy Treatment Market Size (2018-2029)

10.2 Middle East & Africa Peripheral Neuropathy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country (2018-2023)

10.4 Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Eli Lilly

11.1.1 Eli Lilly Company Detail

11.1.2 Eli Lilly Business Overview

11.1.3 Eli Lilly Peripheral Neuropathy Treatment Introduction

11.1.4 Eli Lilly Revenue in Peripheral Neuropathy Treatment Business (2018-2023)

11.1.5 Eli Lilly Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Peripheral Neuropathy Treatment Introduction

11.2.4 Johnson & Johnson Revenue in Peripheral Neuropathy Treatment Business (2018-2023)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Peripheral Neuropathy Treatment Introduction

11.3.4 Novartis Revenue in Peripheral Neuropathy Treatment Business (2018-2023)

11.3.5 Novartis Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Detail

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Peripheral Neuropathy Treatment Introduction

11.4.4 Pfizer Revenue in Peripheral Neuropathy Treatment Business (2018-2023)

11.4.5 Pfizer Recent Development

11.5 Aptinyx

11.5.1 Aptinyx Company Detail

11.5.2 Aptinyx Business Overview

11.5.3 Aptinyx Peripheral Neuropathy Treatment Introduction

11.5.4 Aptinyx Revenue in Peripheral Neuropathy Treatment Business (2018-2023)

11.5.5 Aptinyx Recent Development

11.6 Regenacy Pharmaceuticals

11.6.1 Regenacy Pharmaceuticals Company Detail

11.6.2 Regenacy Pharmaceuticals Business Overview

11.6.3 Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Introduction

11.6.4 Regenacy Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2018-2023)

11.6.5 Regenacy Pharmaceuticals Recent Development

11.7 TEVA Pharmaceutical Industries

11.7.1 TEVA Pharmaceutical Industries Company Detail

11.7.2 TEVA Pharmaceutical Industries Business Overview

11.7.3 TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Introduction

11.7.4 TEVA Pharmaceutical Industries Revenue in Peripheral Neuropathy Treatment Business (2018-2023)

11.7.5 TEVA Pharmaceutical Industries Recent Development

11.8 Immune Pharmaceuticals

11.8.1 Immune Pharmaceuticals Company Detail

11.8.2 Immune Pharmaceuticals Business Overview

11.8.3 Immune Pharmaceuticals Peripheral Neuropathy Treatment Introduction

11.8.4 Immune Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2018-2023)

11.8.5 Immune Pharmaceuticals Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Peripheral Neuropathy Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Calcium Channel α2-delta Ligands

    Table 3. Key Players of Antidepressants

    Table 4. Key Players of Opioids

    Table 5. Key Players of Others

    Table 6. Global Peripheral Neuropathy Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Peripheral Neuropathy Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Peripheral Neuropathy Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Peripheral Neuropathy Treatment Market Share by Region (2018-2023)

    Table 10. Global Peripheral Neuropathy Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Peripheral Neuropathy Treatment Market Share by Region (2024-2029)

    Table 12. Peripheral Neuropathy Treatment Market Trends

    Table 13. Peripheral Neuropathy Treatment Market Drivers

    Table 14. Peripheral Neuropathy Treatment Market Challenges

    Table 15. Peripheral Neuropathy Treatment Market Restraints

    Table 16. Global Peripheral Neuropathy Treatment Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Peripheral Neuropathy Treatment Market Share by Players (2018-2023)

    Table 18. Global Top Peripheral Neuropathy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Neuropathy Treatment as of 2022)

    Table 19. Ranking of Global Top Peripheral Neuropathy Treatment Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Peripheral Neuropathy Treatment Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Peripheral Neuropathy Treatment Product Solution and Service

    Table 23. Date of Enter into Peripheral Neuropathy Treatment Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Peripheral Neuropathy Treatment Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Peripheral Neuropathy Treatment Revenue Market Share by Type (2018-2023)

    Table 27. Global Peripheral Neuropathy Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Peripheral Neuropathy Treatment Revenue Market Share by Type (2024-2029)

    Table 29. Global Peripheral Neuropathy Treatment Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Peripheral Neuropathy Treatment Revenue Market Share by Application (2018-2023)

    Table 31. Global Peripheral Neuropathy Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Peripheral Neuropathy Treatment Revenue Market Share by Application (2024-2029)

    Table 33. North America Peripheral Neuropathy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Peripheral Neuropathy Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Peripheral Neuropathy Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Peripheral Neuropathy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Peripheral Neuropathy Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Peripheral Neuropathy Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Peripheral Neuropathy Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Peripheral Neuropathy Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Peripheral Neuropathy Treatment Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Peripheral Neuropathy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Peripheral Neuropathy Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Peripheral Neuropathy Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Peripheral Neuropathy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Peripheral Neuropathy Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Eli Lilly Company Detail

    Table 49. Eli Lilly Business Overview

    Table 50. Eli Lilly Peripheral Neuropathy Treatment Product

    Table 51. Eli Lilly Revenue in Peripheral Neuropathy Treatment Business (2018-2023) & (US$ Million)

    Table 52. Eli Lilly Recent Development

    Table 53. Johnson & Johnson Company Detail

    Table 54. Johnson & Johnson Business Overview

    Table 55. Johnson & Johnson Peripheral Neuropathy Treatment Product

    Table 56. Johnson & Johnson Revenue in Peripheral Neuropathy Treatment Business (2018-2023) & (US$ Million)

    Table 57. Johnson & Johnson Recent Development

    Table 58. Novartis Company Detail

    Table 59. Novartis Business Overview

    Table 60. Novartis Peripheral Neuropathy Treatment Product

    Table 61. Novartis Revenue in Peripheral Neuropathy Treatment Business (2018-2023) & (US$ Million)

    Table 62. Novartis Recent Development

    Table 63. Pfizer Company Detail

    Table 64. Pfizer Business Overview

    Table 65. Pfizer Peripheral Neuropathy Treatment Product

    Table 66. Pfizer Revenue in Peripheral Neuropathy Treatment Business (2018-2023) & (US$ Million)

    Table 67. Pfizer Recent Development

    Table 68. Aptinyx Company Detail

    Table 69. Aptinyx Business Overview

    Table 70. Aptinyx Peripheral Neuropathy Treatment Product

    Table 71. Aptinyx Revenue in Peripheral Neuropathy Treatment Business (2018-2023) & (US$ Million)

    Table 72. Aptinyx Recent Development

    Table 73. Regenacy Pharmaceuticals Company Detail

    Table 74. Regenacy Pharmaceuticals Business Overview

    Table 75. Regenacy Pharmaceuticals Peripheral Neuropathy Treatment Product

    Table 76. Regenacy Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2018-2023) & (US$ Million)

    Table 77. Regenacy Pharmaceuticals Recent Development

    Table 78. TEVA Pharmaceutical Industries Company Detail

    Table 79. TEVA Pharmaceutical Industries Business Overview

    Table 80. TEVA Pharmaceutical Industries Peripheral Neuropathy Treatment Product

    Table 81. TEVA Pharmaceutical Industries Revenue in Peripheral Neuropathy Treatment Business (2018-2023) & (US$ Million)

    Table 82. TEVA Pharmaceutical Industries Recent Development

    Table 83. Immune Pharmaceuticals Company Detail

    Table 84. Immune Pharmaceuticals Business Overview

    Table 85. Immune Pharmaceuticals Peripheral Neuropathy Treatment Product

    Table 86. Immune Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2018-2023) & (US$ Million)

    Table 87. Immune Pharmaceuticals Recent Development

    Table 88. Research Programs/Design for This Report

    Table 89. Key Data Information from Secondary Sources

    Table 90. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Peripheral Neuropathy Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Peripheral Neuropathy Treatment Market Share by Type: 2022 VS 2029

    Figure 3. Calcium Channel α2-delta Ligands Features

    Figure 4. Antidepressants Features

    Figure 5. Opioids Features

    Figure 6. Others Features

    Figure 7. Global Peripheral Neuropathy Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Peripheral Neuropathy Treatment Market Share by Application: 2022 VS 2029

    Figure 9. Platinum Agents Case Studies

    Figure 10. Taxanes Case Studies

    Figure 11. Vinca Alkaloids Case Studies

    Figure 12. Others Case Studies

    Figure 13. Peripheral Neuropathy Treatment Report Years Considered

    Figure 14. Global Peripheral Neuropathy Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Peripheral Neuropathy Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Peripheral Neuropathy Treatment Market Share by Region: 2022 VS 2029

    Figure 17. Global Peripheral Neuropathy Treatment Market Share by Players in 2022

    Figure 18. Global Top Peripheral Neuropathy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Neuropathy Treatment as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Peripheral Neuropathy Treatment Revenue in 2022

    Figure 20. North America Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Peripheral Neuropathy Treatment Market Share by Country (2018-2029)

    Figure 22. United States Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Peripheral Neuropathy Treatment Market Share by Country (2018-2029)

    Figure 26. Germany Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Peripheral Neuropathy Treatment Market Share by Region (2018-2029)

    Figure 34. China Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Peripheral Neuropathy Treatment Market Share by Country (2018-2029)

    Figure 42. Mexico Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Peripheral Neuropathy Treatment Market Share by Country (2018-2029)

    Figure 46. Turkey Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Peripheral Neuropathy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Eli Lilly Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2018-2023)

    Figure 49. Johnson & Johnson Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2018-2023)

    Figure 50. Novartis Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2018-2023)

    Figure 51. Pfizer Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2018-2023)

    Figure 52. Aptinyx Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2018-2023)

    Figure 53. Regenacy Pharmaceuticals Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2018-2023)

    Figure 54. TEVA Pharmaceutical Industries Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2018-2023)

    Figure 55. Immune Pharmaceuticals Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2018-2023)

    Figure 56. Bottom-up and Top-down Approaches for This Report

    Figure 57. Data Triangulation

    Figure 58. Key Executives Interviewed